Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Nutt

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Current Opinion in Pharmacology|January 12, 2002
Neuroimmunophilin ligands in the treatment of Parkinson's diseaseBruce G Gold, John G Nutt
Nature Reviews. Neurology|October 8, 2010
Parkinson disease: deep brain stimulation versus best medical therapy for PDMatthew A Brodsky, John G Nutt
Journal of Parkinson'S Disease|December 26, 2018
Non-Dopaminergic TherapiesJohn G Nutt, Nicolaas I Bohnen
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
Interpreting the results of Parkinson's disease clinical trials: time for a changeNick H G Holford, John G Nutt
Experimental Neurology|May 5, 2005
Direction-specific postural instability in subjects with Parkinson's diseaseFay B Horak, Diana Dimitrova, John G Nutt
Journal of Neurophysiology|August 29, 2003
Postural muscle responses to multidirectional translations in patients with Parkinson's diseaseDiana Dimitrova, Fay B Horak, John G Nutt
Lancet (London, England)|June 3, 2004
Parkinson's diseaseAli Samii, John G Nutt, Bruce R Ransom
Parkinsonism & Related Disorders|February 26, 2018
Apraxia of gait- or apraxia of postural transitions?Marian L Dale, Carolin Curtze, John G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|May 25, 2006
OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's diseaseMatthew A Brodsky, Penelope Hogarth, John G Nutt
Annals of Neurology|June 3, 2004
The dopamine transporter: importance in Parkinson's diseaseJohn G Nutt, Julie H Carter, Gary J Sexton
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Current Opinion in Pharmacology|January 12, 2002
Neuroimmunophilin ligands in the treatment of Parkinson's diseaseBruce G Gold, John G Nutt
Nature Reviews. Neurology|October 8, 2010
Parkinson disease: deep brain stimulation versus best medical therapy for PDMatthew A Brodsky, John G Nutt
Journal of Parkinson'S Disease|December 26, 2018
Non-Dopaminergic TherapiesJohn G Nutt, Nicolaas I Bohnen
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
Interpreting the results of Parkinson's disease clinical trials: time for a changeNick H G Holford, John G Nutt
Experimental Neurology|May 5, 2005
Direction-specific postural instability in subjects with Parkinson's diseaseFay B Horak, Diana Dimitrova, John G Nutt
Journal of Neurophysiology|August 29, 2003
Postural muscle responses to multidirectional translations in patients with Parkinson's diseaseDiana Dimitrova, Fay B Horak, John G Nutt
Lancet (London, England)|June 3, 2004
Parkinson's diseaseAli Samii, John G Nutt, Bruce R Ransom
Parkinsonism & Related Disorders|February 26, 2018
Apraxia of gait- or apraxia of postural transitions?Marian L Dale, Carolin Curtze, John G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|May 25, 2006
OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's diseaseMatthew A Brodsky, Penelope Hogarth, John G Nutt
Annals of Neurology|June 3, 2004
The dopamine transporter: importance in Parkinson's diseaseJohn G Nutt, Julie H Carter, Gary J Sexton
Pageof 15